Madrona Venture Group, LLC

Est. AUM

$22.1M

13F long equity, this entity only

Positions

Period

Dec 2025 (Q4)

SEC EDGAR

Dec 2025 (Q4)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	NAUTILUS BIOTECHNOLOGY INC	COM	$11.7M	6020770	53.24%	SOLE
2	UIPATH INC	CL A	$10.0M	607673	45.16%	SOLE
3	GINKGO BIOWORKS HOLDINGS, INC.	CL A	$353K	42430	1.60%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.